Free preview. Sign up free to see the team, full portfolio, ownership chain, and shareholding history.
Nicholas John Cross investment portfolio
Nicholas John Cross has made numerous investments in companies such as Accession Therapeutics within the Biotech sector.
Portfolio
1
Team
0
Shareholding changes (3)
Nicholas John Cross's positions across portfolio companies2025
- ORDINARY 85,290 → 137,616
- A SHARES 0 → 25,000
2024
- ORDINARY 59,127 → 85,290
Articles (1)
- Accession Therapeutics secures £5.7m to advance targeted cancer immunotherapies26 Mar 2026Accession Therapeutics